Major side effects occur after coronary syndrome

Published Date: 13 Mar 2023

OSA itself predicted the incidence of MACCE in non-obese patients.

Read Full News

Latest News

Insurers Fail to Get Specific on Prior Authorization Reforms

An industry trade group says prior authorization requirements have declined by 11% after last year’s pledge, but the numbers are fuzzy.

MHRA Approves Olezarsen for Rare Lipid Disorder

The MHRA has approved olezarsen for familial chylomicronaemia syndrome, a rare disorder linked to life-threatening pancreatitis.

Long COVID May Increase Your Heart Disease Risk

Individuals with long COVID face a substantially higher risk of developing cardiovascular disease — particularly cardiac arrhythmias and coronary artery disease — than those without long COVID.

Tirzepatide Bests Semaglutide in 12-Month Real-World Study

Tirzepatide is associated with a greater mean percent body weight reduction than semaglutide in adults with obesity or overweight and one or more related complications.

BP Lower Than Target in Many With Coronary Heart Disease

Over one third of patients with coronary heart disease have blood pressure below targets recommended by European guidelines and have elevated risks for heart and kidney diseases.

Lower LDL-C Target May Improve CV Outcomes

A study finds direct evidence to support guideline changes that promote lower targets for low-density lipoprotein cholesterol.

Todays Updates

A Nutritional Experiment: State-by-State Changes in SNAP

Dr Wilkoff wonders what the effects will be of 12 states proposing changes to restricted foods under SNAP.

Trump Officials Consider Ophthalmologist Hemmati for Top Vaccine Post, Reports Say

The Trump administration is considering appointing Houman Hemmati, an ⁠ophthalmologist and a frequent Fox News guest, to lead the FDA's Center ⁠for Biologics Evaluation and...

Residency Training May Formalize Digital Competencies

Medical residents report limited structured training in AI and digital health despite increasing clinical relevance.

Reusable Catheters Just as Safe as Disposables

Reusable catheter strategies may be as safe as single-use devices for preventing UTIs, but questions remain about their practical use.

A Simple Test Could Predict a Patient’s Final 24 Hours

New research suggests the loss of the corneal reflex — a classic marker of brain death — could help clinicians make more specific assessments during the final days and hours of life.

Multidose Ibuprofen Regimen Eases IUD Insertion Pain

Taking three doses of ibuprofen before the insertion of an intrauterine device reduces pain during the procedure compared with a placebo.

AI Chatbots Vary Widely on Fake Medical References

A study of nine AI chatbots found hallucination rates from 0% to 34%, with Grok 3 performing the worst and Perplexity Research being most reliable.

Todays Updates

A Nutritional Experiment: State-by-State Changes in SNAP

Dr Wilkoff wonders what the effects will be of 12 states proposing changes to restricted foods under SNAP.

Trump Officials Consider Ophthalmologist Hemmati for Top Vaccine Post, Reports Say

The Trump administration is considering appointing Houman Hemmati, an ⁠ophthalmologist and a frequent Fox News guest, to lead the FDA's Center ⁠for Biologics Evaluation and...

Residency Training May Formalize Digital Competencies

Medical residents report limited structured training in AI and digital health despite increasing clinical relevance.

Reusable Catheters Just as Safe as Disposables

Reusable catheter strategies may be as safe as single-use devices for preventing UTIs, but questions remain about their practical use.

A Simple Test Could Predict a Patient’s Final 24 Hours

New research suggests the loss of the corneal reflex — a classic marker of brain death — could help clinicians make more specific assessments during the final days and hours of life.

Multidose Ibuprofen Regimen Eases IUD Insertion Pain

Taking three doses of ibuprofen before the insertion of an intrauterine device reduces pain during the procedure compared with a placebo.

AI Chatbots Vary Widely on Fake Medical References

A study of nine AI chatbots found hallucination rates from 0% to 34%, with Grok 3 performing the worst and Perplexity Research being most reliable.

Latest News

An industry trade group says prior authorization requirements have declined by 11% after last year’s pledge, but the numbers are fuzzy.

The MHRA has approved olezarsen for familial chylomicronaemia syndrome, a rare disorder linked to life-threatening pancreatitis.

Individuals with long COVID face a substantially higher risk of developing cardiovascular disease — particularly cardiac arrhythmias and coronary artery disease — than those without long COVID.

Tirzepatide is associated with a greater mean percent body weight reduction than semaglutide in adults with obesity or overweight and one or more related complications.

Over one third of patients with coronary heart disease have blood pressure below targets recommended by European guidelines and have elevated risks for heart and kidney diseases.

A study finds direct evidence to support guideline changes that promote lower targets for low-density lipoprotein cholesterol.

News All Time

Veterans Often Miss Out on Quadruple Therapy for HFrEF

Most US veterans who have new heart failure with reduced ejection fraction do not receive all four classes of guideline-directed medical therapy, and many die before starting full therapy, a study finds.

Stable Patients May Safely End Beta-Blockers Post-MI

Stable patients who stop taking beta-blockers a year or more after a heart attack fare no worse than those who keep taking them, a study conducted in South Korea finds.

Empagliflozin May Boost Exercise Tolerance in T2D

In patients with type 2 diabetes, 6 months of empagliflozin therapy vs sitagliptin therapy is tied to a modest increase in the fat oxidation rate during exercise of low-to-moderate intensity.

Should Your Patient Be on Statins? Maybe the Eyes Can Tell

A trial of an AI algorithm that uses retina images to evaluate the risk for atherosclerotic cardiovascular disease demonstrates a high level of accuracy.

Europe’s DNR Divide: Why CPR Discussions Are So Difficult

How do you speak with a deteriorating, in-hospital patient about resuscitation decisions? Physician confidence and legal frameworks vary, with direct impacts on patients.

Fluid Monitoring Device Can Improve HFpEF Outcomes

By early detection of fluid in the lungs, a device allows early therapy adjustments to reduce all-cause mortality in patients with heart failure with preserved ejection fraction.

Liraglutide Lessens Sleep Apnea in COPD With Obesity

Liraglutide reduced obstructive sleep apnea severity and improved quality of life in patients with overweight or obesity and COPD in a randomized trial.

Australia Bans Use of Genetic Testing Data by Life Insurers

Australia has banned life insurance companies from using genetic testing information to deny or restrict policies.

Inside the Quest to Predict Disease Before Symptoms Strike

From smartwatches to DNA fragments, scientists are building a ‘dashboard’ for human health, but a high-profile trial shows how difficult it is to prove the tech can save lives.

Can Vitamin D Promote a Healthier Gut in IBD?

Vitamin D supplementation is linked to less disease activity and inflammation in inflammatory bowel disease and may restore healthy interactions between the immune system and the gut.

Two Oral GLP-1s Increase Options for Patient Care

Eli Lilly and Novo Nordisk are in heated competition over orforglipron versus oral semaglutide, respectively, while injectables remain the more potent obesity treatment options.

Impella Comes Up Short in High-Risk PCI: CHIP-BCIS3

High-risk patients with left ventricular dysfunction fare as well, or better, without the support of a microaxial flow pump during complex PCI procedures than those provided with a microaxial flow pump.

Shingles Vaccine Lowers Cardiovascular Risk

Patients with atherosclerotic cardiovascular disease who had received herpes zoster vaccination saw reductions in major adverse cardiac events.

Younger Age Offers No Protection From HFrEF Deaths

Patients with heart failure with reduced ejection fraction, especially those aged 40-49 years, have higher 5-year mortality than peers from the general population.

Active Breath Control Cuts Radiation Dose to Heart

Active breath control significantly reduced radiation dose to the heart and a major artery during treatment for left-sided breast cancer, new data show.

Hormonal Contraception and IIH Risk: New Data

A systematic review and meta-analysis sheds light on the debated association between hormonal contraception and risk for idiopathic intracranial hypertension.

Recommended News For You

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'

New Gene Therapy Nears EU Nod for Bladder Cancer

A novel blood test may enable the early identification of common, fatal cancers.

Nuclear missile workers are contracting cancer: They blame the bases

In breast cancer patients with nodes positive, preoperative hydroxyprogesterone may enhance disease-free survival.

Trump slashed US cancer research by 31 percent: Senate report

Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer

Recommended Articles For You

Everything You Need to Know About HTLV: A Comprehensive Guide  

HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review 

Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment 

Exploring the Causes and Treatments of Thrombocytopenia: A Comprehensive Guide 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

There has been a new target found that might stop blood cancer.

2.

Hypnotherapy may offer real benefits for cancer patient care

3.

Kekoa Taparra, a native Hawaiian physician-scientist, is becoming well-known.

4.

Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.

5.

Millions of men could benefit from faster scan to diagnose prostate cancer

1.

Unlocking the Potential of Elotuzumab: A Promising New Cancer Treatment

2.

Navigating the Complexity of Peritoneal Carcinomatosis: A Guide for Patients and Caregivers

3.

Optimizing Oncology Practice Revenue: Billing Software, Payer Trends, and Financial Navigation Tools

4.

Beyond the Blood: Expanding CAR T-Cell Therapy to Solid Tumors- A New Era of Precision Oncology

5.

AI in the War on Cancer: How Digital Tools are Revolutionizing Oncology

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

2.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

4.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot